Pulse Signal Patents (Class 607/72)
  • Patent number: 11944820
    Abstract: Neurostimulation of a mixed nerve comprising a plurality of nerve fibre types. An implantable electrode array comprising a plurality of electrodes is positioned proximal to the mixed nerve. An electrical stimulus is delivered from at least one nominal stimulus electrode of the implantable electrode array, in accordance with a set of stimulus parameters. A recording of the electrophysiological response evoked by the electrical stimulus is obtained from at least one nominal recording electrode of the implantable electrode array. The recording is analysed by assessing one or more selected characteristics of the recording, and from the observed selected characteristics a level of recruitment of one or more fibre types recruited by the electrical stimulus is identified. The stimulus parameters are refined in a manner to effect selective recruitment of one or more fibre types relative to other fibre types of the mixed nerve.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: April 2, 2024
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Gerrit Eduard Gmel
  • Patent number: 11931096
    Abstract: System for electrically ablating tissue of a patient through a plurality of electrodes includes a memory, a processor and a treatment control module stored in the memory and executable by the processor. The treatment control module generates an estimated treatment region based on the number of electrical pulses to be applied.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: March 19, 2024
    Assignee: ANGIODYNAMICS, INC.
    Inventors: Peter Callas, David Warden, Robert M. Pearson
  • Patent number: 11918271
    Abstract: High-voltage pulses ablation systems and methods are used to ablate tissue and form lesions. A variety of different electrophysiology devices, such as catheters, surgical probes, and clamps, may be used to position one or more electrodes at a target location. Electrodes can be connected to power supply lines and, in some instances, the power to the electrodes can be controlled on an electrode-by-electrode basis. High-voltage pulse sequences provide a total amount of heating that is typically less than that which is observed with thermally-based radiofrequency energy ablation protocols.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: March 5, 2024
    Assignee: AtriCure, Inc.
    Inventor: David K. Swanson
  • Patent number: 11865342
    Abstract: Slurry electrodes can deliver direct current (DC) nerve conduction block to neural tissue. Such slurry electrodes can include an ionically conductive membrane having a first side and a second side. Slurry electrodes can also include a mechanism that is configured to encapsulate a slurry against the first side of the ionically conductive membrane. The slurry can include an ionically conductive material and a plurality of electrically conducting high surface area particles. The mechanism and the first side of the ionically conductive membrane make up a housing for the slurry. Slurry electrodes can also include a connector configured to establish an electrical connection between the slurry and the DC generator.
    Type: Grant
    Filed: August 18, 2022
    Date of Patent: January 9, 2024
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Tina L. Vrabec, Jesse S. Wainright, Niloy Bhadra, Kevin L. Kilgore
  • Patent number: 11857789
    Abstract: A neurostimulation (NS) system and method are provided. The NS system includes an array of electrodes positioned within a patient. The array of electrodes includes an active electrode. The active electrode is configured to be a cathode electrode located proximate to neural tissue of interest that is associated with a target region. The NS system includes an anode electrode and an electromagnetic interference (EMI) antenna. A control circuit is configured to control delivery of a NS therapy during a therapy delivery interval. The NS therapy is to be delivered between the anode electrode and the active electrode. The NS system develops a residual voltage between the anode electrode and the active electrode over the therapy delivery interval. A current regulator (CR) circuit is connected to the cathode electrode. The CR circuit is configured to control current flow through the cathode electrodes.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: January 2, 2024
    Assignee: ADVANCED NEUROMODULATION SYSTEMS, INC.
    Inventors: Steven Boor, Daran DeShazo
  • Patent number: 11745010
    Abstract: A nerve stimulation system including at least one nerve interface device is disclosed. The device includes a cuff portion having an assembled position in which the cuff portion forms at least part of a passageway for receiving a nerve along a longitudinal axis passing through the passageway; and first and second rings of electrodes mounted on the cuff portion, each ring of electrodes including a plurality of electrodes, and wherein each electrode in the first ring has a corresponding longitudinally-aligned electrode in the second ring so as to form a plurality of pairs of electrodes spaced apart from each other along the longitudinal axis. The system includes a stimulation device in communication with the pairs of electrodes to generate different electrical signals for the pairs of electrodes and a control system that causes the different signals to causes different physiological responses.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: September 5, 2023
    Assignees: GALVANI BIOELECTRONICS LIMITED, UCL BUSINESS LTD.
    Inventors: Matteo Donega, Daniel Chew, David Holder, Kirill Aristovich
  • Patent number: 11724108
    Abstract: Electrical stimulation of neural activity in the neural innervation of the spleen provides a useful way to treat acute medical conditions. The disclosed systems and methods stimulate the neural activity of a nerve supplying a spleen, wherein the nerve is associated with a neurovascular bundle, such that the electrical signal produces an improvement in a physiological parameter indicative of treatment of an acute medical condition.
    Type: Grant
    Filed: July 25, 2022
    Date of Patent: August 15, 2023
    Assignee: Galvani Bioelectronics Limited
    Inventors: Daniel John Chew, Matteo Donega, Isha Gupta
  • Patent number: 11691008
    Abstract: A neuromimetic stimulating apparatus includes a feedback detector configured to detect a feedback signal from a target to be stimulated, a controller configured to analyze a waveform of the detected feedback signal and determine a parameter based on the analyzed waveform of the detected feedback signal, and a signal generator configured to generate a stimulus signal corresponding to the detected feedback signal based on the determined parameter.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: July 4, 2023
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Hyungwoo Lee, Sang Joon Kim, JongPal Kim
  • Patent number: 11672972
    Abstract: A nerve interface device including at least one cuff portion having an assembled position in which the cuff portion forms at least part of a passageway for receiving a nerve along a longitudinal axis passing through the passageway; and first and second rings of electrodes mounted on the at least one cuff portion, each ring of electrodes including a plurality of electrodes. Each electrode in the first ring has a corresponding longitudinally-aligned electrode in the second ring so as to form a plurality of pairs of electrodes spaced apart from each other along the longitudinal axis. The plurality of pairs of electrodes includes at least a first pair of electrodes, the first pair of electrodes mounted on the at least one cuff portion. The at least one cuff portion includes an asymmetric configuration about a central axis perpendicular to the longitudinal cuff axis.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: June 13, 2023
    Assignees: Galvani Bioelectronics Limited, UCL Business PLC
    Inventors: Rizwan Bashirullah, Gerald Edwin Hunsberger, Matteo Donega, Daniel Chew, David Holder, Kirill Aristovich
  • Patent number: 11623093
    Abstract: Neuromodulation is used to enhance left ventricular relaxation and/or left ventricular contractility, during contemporaneous use of a mechanical circulatory support device to increase cardiac output or aid in unloading the heart. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: April 11, 2023
    Assignee: NuXcel Limited
    Inventors: Michael Cuchiara, Stephen C. Masson
  • Patent number: 11577082
    Abstract: Devices and methods for the stimulation of neural signaling of an apical splenic nerve, the device having a transducer for placement on or around the apical splenic nerve, and a signal generator to generate a signal that stimulates or inhibits the neural activity of the apical splenic nerve to produce a physiological response. The transducer has at least one electrode, and the signal generator is a voltage or current source. The stimulation electrical signal has a frequency of between 1 Hz and 50 Hz.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: February 14, 2023
    Assignees: Galvani Bioelectronics Limited, GlaxoSmithKline Intellectual Property Development Limited, Université de Nice Sophia-Antipolis, Centre Nationale de La Recherche Scientifique
    Inventors: Philippe Blancou, Nicolas Glaichenhaus, Arun Sridhar
  • Patent number: 11571154
    Abstract: An IoT device and system improves on prior approaches to tracking and analyzing symptoms and behavior of special needs individuals. The IoT device may include one or more buttons that can be pressed or held for an extended time by the user. Button presses and duration may be registered in a remote computer as being associated to a symptom or behavior. Patterns may be registered based on a sequence of the button presses and duration. Triggered button events may be collected and transmitted to a host server/network for re-transmission to support team members. In some embodiments, a machine learning module may analyze the collected data for patterns and/or deviations of behavior, which may be displayed to team members. In some embodiments, an automatic prognosis may be generated.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: February 7, 2023
    Inventor: Nikody Keating
  • Patent number: 11534608
    Abstract: Transdermal electrical stimulation (TES) applicators that are wearable and configured to attached to a subject's pinna (ear) and adapted to apply TES to modulate the subject's cognitive and/or physiological state. These apparatuses may be configured so that they can be worn against the ear (e.g., the cymba of the ear) to deliver TES. Also described herein are methods of using them to modulate a subject's cognitive state. These TES applicators may also be adapted to function as audio headphones for concurrent delivery of TES and audible signals (e.g., music).
    Type: Grant
    Filed: September 30, 2019
    Date of Patent: December 27, 2022
    Assignee: IST, LLC
    Inventors: William J. Tyler, Wing Law, Douglas Jeffery, Rafal Piersiak
  • Patent number: 11491081
    Abstract: A wearable stimulator device can be used to treat nausea and vomiting resulting from pregnancy, gastroparesis, virtual reality use, motion sickness, chemotherapy, and post-surgical nausea and vomiting, or other conditions by stimulating the P6 point of a user's forearm. A method of treating nausea includes monitoring one or more physiological parameters of a user via a wearable device, for example a smartwatch. Based on the one or more physiological parameters, the P6 point of the user's forearm can be stimulated for a predetermined time, for example via vibrational stimulation effected via a smartwatch or other wearable device. Data regarding the user's physiological parameters, stimulation sessions, and user-provided input regarding treatment efficacy and user symptoms can be collected and analyzed at scale to develop improved treatment regimes, for example modifying stimulation waveforms and/or timing, and identifying physiological parameters useful for predicting the onset of nausea.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: November 8, 2022
    Assignee: Sense Relief Inc.
    Inventors: Andrei Akaikine, Sidhartha Ranjit Sinha, Moshe Zilversmit
  • Patent number: 11471676
    Abstract: Tumor treating fields (TTFields) can be delivered by implanting a plurality of sets of implantable electrode elements within a person's body. Temperature sensors positioned to measure the temperature at the electrode elements are also implanted, along with a circuit that collects temperature measurements from the temperature sensors. In some embodiments, an AC voltage generator configured to apply an AC voltage across the plurality of sets of electrode elements is also implanted within the person's body.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: October 18, 2022
    Assignee: Novocure GmbH
    Inventors: Yoram Wasserman, Zeev Bomzon, Hadas Sara Hershkovich, Ariel Naveh, Moshe Giladi, Eilon Kirson, Golan Bar-Tal, Tali Voloshin-Sela
  • Patent number: 11464978
    Abstract: Electrical stimulation of neural activity in the neural innervation of the spleen that is associated with neurovascular bundles provides a useful way to treat acute medical conditions, such as trauma, hemorrhaging and shock.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: October 11, 2022
    Assignee: Galvani Bioelectronics Limited
    Inventors: Daniel John Chew, Matteo Donega, Isha Gupta
  • Patent number: 11446502
    Abstract: Stimulation of neural activity in a nerve supplying the spleen, wherein the nerve is associated with a neurovascular bundle, can modulate pro- and anti-inflammatory molecules levels, thereby reducing inflammation and providing ways of treating inflammatory disorders. The invention provides improved ways of treating inflammatory disorders which minimize off-target effects.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: September 20, 2022
    Assignee: Galvani Bioelectronics Limited
    Inventors: Matteo Donega, Daniel John Chew, Isha Gupta
  • Patent number: 11426585
    Abstract: The present disclose relates to slurry electrodes that can deliver direct current (DC) nerve conduction block to neural tissue. Such slurry electrodes can include an ionically conductive membrane having a first side and a second side. Slurry electrodes can also include a mechanism that is configured to encapsulate a slurry against the first side of the ionically conductive membrane. The slurry can include an ionically conductive material and a plurality of electrically conducting high surface area particles. The mechanism and the first side of the ionically conductive membrane make up a housing for the slurry. Slurry electrodes can also include a connector configured to establish an electrical connection between the slurry and the DC generator.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: August 30, 2022
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Tina L. Vrabec, Jesse S. Wainright, Niloy Bhadra, Kevin L. Kilgore
  • Patent number: 11400279
    Abstract: The system and method of the present invention takes advantage of the laryngeal adductor reflex (LAR), previously thought to be repressed during general anesthesia, for CIONM without placement of an electrode on the vagus nerve.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: August 2, 2022
    Assignee: Icahn School of Medicine at Mount Sinai
    Inventors: Catherine F. Sinclair, Sedat Ulkatan, Maria Jose Tellez Garbayo
  • Patent number: 11369797
    Abstract: A neural stimulation and recording electrode assembly includes a selectively deformable guide tube. The guide tube includes a plurality of sequentially coupled connecting structures, wherein each connecting structure of the plurality of connecting structures has a respective central axis, and wherein at least one of the plurality of connecting structures is selectively deformable relative to the central axis of a sequential connecting structure of the plurality of connecting structures such that the central axis of the selectively deformable connecting structure is angularly oriented relative to the central axis of the sequential connecting structure.
    Type: Grant
    Filed: December 30, 2019
    Date of Patent: June 28, 2022
    Assignee: STEREONEUROSTIM, LLC
    Inventor: Arash Hadipour-Niktarash
  • Patent number: 11351368
    Abstract: Methods and apparatuses (systems, devices, etc.) for treating biological tissue to evoke one or more desirable biological and/or physiological effects using pulsed electric fields in the sub-microsecond range at very low electric field strength (e.g., less than 1 kV/cm) but at high (e.g., megahertz) frequencies.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: June 7, 2022
    Assignee: Old Dominion University Research Foundation
    Inventors: Andrei G. Pakhomov, Shu Xiao, Olga N. Pakhomova, Maura Casciola
  • Patent number: 11331480
    Abstract: In some embodiments, systems and methods can include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the saphenous and/or tibial nerves. The stimulation could include burst stimulation, and involve receiving an input relating to autonomic nervous system activity of the patient, and modifying at least one brain or spinal cord autonomic feedback loop relating to bladder function based on the input to balance parasympathetic and sympathetic nervous system activity of the patient.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: May 17, 2022
    Assignee: Cala Health, Inc.
    Inventors: Samuel Richard Hamner, Serena HanYing Wong, Kathryn H. Rosenbluth, Peter Lin, Shahid Mallick, Erika Kristine Ross
  • Patent number: 11298502
    Abstract: Non-pharmaceuticals method of treating the effects of addiction withdrawal are described. The method includes providing a person with stimuli include visual and/or auditory stimuli which are pulsed at the rate of various types of brain waves. The use of the method lessens various withdrawal symptoms, such as anxiety, sleepiness, sweating, tearing of the eyes, running of the nose, goosebumps, shaking, hot flushes, cold flushes, bones aching, muscles aching, restlessness, nausea, vomiting, muscle twitching, stomach cramps, pain, the need to use an opioid, the desire to use an opioid, sleep disturbances. and the use of rescue medications.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: April 12, 2022
    Assignee: SANA HEALTH, INC.
    Inventor: Richard Hanbury
  • Patent number: 11253182
    Abstract: The present specification discloses an intraoperative neurophysiological monitoring (IONM) system including a computing device capable of executing an IONM software engine, a stimulation module having multiple ports and various stimulation components and recording electrodes. The system is used to implement transcranial electrical stimulation and motor evoked potential monitoring by positioning at least one recording electrode on a patient, connecting the stimulation components to at least one port on the stimulation module, positioning the stimulation components on a patient's head, activating, using the IONM software engine, at least one port, delivering stimulation to the patient; and recording a stimulatory response on the patient.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: February 22, 2022
    Inventors: Rose Rehfeldt, Ivan Amaya, John A. Cadwell, John A. Cadwell, Jr.
  • Patent number: 11197999
    Abstract: A patient treatment unit for delivering non-invasive pulsed energy to living tissue with a probe stimulus generator circuit configured to output, as a treatment signal, a sequence of DC electrical pulses at a controlled pulse frequency of about 20 kHz and having a pulse voltage defined by a variable supply voltage of the probe stimulus generator circuit. The unit includes primary and secondary probes for contacting a body, an intensity adjustment circuit configured to control the variable supply voltage, and an electronic timer display configured to display an elapsed time in decimal numbers in minute and second format. An electrical current of the pulses is in a range of 0.1-2 mA while the probes are contacting the body. An operating output voltage across the probes while conducting the treatment signal does not exceed a maximum operating output voltage of 165 VDC while the probes are contacting the body.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: December 14, 2021
    Assignee: TrueRelief, LLC
    Inventor: John Crosson
  • Patent number: 11134998
    Abstract: The present invention generally relates to improved medical devices, systems, and methods. In many embodiments, devices, systems, and methods for locating and treating a target nerve with integrated cold therapy and electrical stimulation systems are provided. For example, nerve stimulation and cryoneurolysis may be delivered concurrently or alternately with the cryo-stimulation device. In some embodiments, the device may be operated by a single operator or clinician. Accordingly, embodiments of the present disclosure may improve nerve targeting during cryoneurolysis procedures. Improvements in nerve localization and targeting may increase treatment accuracy, physician confidence in needle placement during treatment, and clinical efficacy and safety. In turn, such improvements may decrease overall treatment times, the number of repeat treatments, and the re-treatment rate.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: October 5, 2021
    Assignee: Pacira CryoTech, Inc.
    Inventors: Ann Lee Cross, Erika Danielle Anderson-Bolden, Jessica Preciado Dummett, Eric Theodore Johansson, Paul Tanaka-Roche
  • Patent number: 11083892
    Abstract: The present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for minimally invasive, targeted, vagus nerve stimulation (pVNS), and the efficacy of this approach with respect to microglial activation and the amelioration of cognitive dysfunction. The systems and methods of neuromodulation disclosed herein can be used to facilitate the treatment of various diseases associated with pathological neural activity.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: August 10, 2021
    Assignee: DUKE UNIVERSITY
    Inventors: Niccolo Terrando, William Huffman, Warren Grill
  • Patent number: 11020585
    Abstract: Damage from autoimmune diseases can be prevented or minimized by positioning a plurality of electrodes in or on a subject's body, and applying an AC voltage between the plurality of electrodes so as to impose an alternating electric field through the tissue that is being attacked by the autoimmune disease and/or draining lymph nodes associated with that tissue. The frequency and field strength of the alternating electric field are selected such that the alternating electric field inhibits proliferation of T cells in the tissue to an extent that reduces damage that is caused by the autoimmune disease.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: June 1, 2021
    Assignee: Novocure GmbH
    Inventors: Yaniv Alon, Tali Voloshin-Sela, Moshe Giladi
  • Patent number: 11020590
    Abstract: Provided herein are methods of generating a biologically effective unipolar nanosecond electric pulse by superposing two biologically ineffective bipolar nanosecond electric pulses and related aspects, such as electroporation and/or therapeutic applications of these methods to non-invasively target electrostimulation (ES) selectively to deep tissues and organs.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: June 1, 2021
    Assignee: OLD DOMINION UNIVERSITY RESEARCH FOUNDATION
    Inventors: Andrei G. Pakhomov, Olga N. Pakhomova, Shu Xiao
  • Patent number: 10980596
    Abstract: This invention relates generally to apparatus and methods for tightening tissue of the female genitalia by heating targeted connective tissue with radiant energy, while cooling the mucosal epithelial surface over the target tissue to protect it from the heat. Embodiments include a treatment tip that comprises both an energy delivery element and a cooling mechanism. As the treatment tip contacts the epithelial mucosa, the tip cools the mucosa by contact, and delivers energy through the epithelium to the underlying tissue, thereby creating a reverse thermal gradient. The effect of the applied heat is to remodel genital tissue by tightening it. Such remodeling may include a tighter vagina and a tighter introitus. The tightening may be a consequence of thermal denaturation of collagen as well as a longer term healing response in the tissue that includes an increased deposition of collagen.
    Type: Grant
    Filed: February 23, 2015
    Date of Patent: April 20, 2021
    Assignee: Viveve, Inc.
    Inventor: Jonathan B. Parmer
  • Patent number: 10974041
    Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: April 13, 2021
    Assignees: GALVANI BIOELECTRONICS LIMITED, ACADEMISCH MEDISCH CENTRUM
    Inventors: Daniel John Chew, Wouter Jacob De Jonge, Hans Jakob Kristoffer Famm, Sonal Patel, Olaf Welting
  • Patent number: 10960206
    Abstract: Described is a low voltage, pulsed electrical stimulation device for controlling expression of, for example, follistatin, a muscle formation promotion protein, by tissues. Epicardial stimulation is especially useful for heart treatment. Follistatin controlled release is also useful for treating other ailments, such as erectile dysfunction, aortic aneurysm, and failing heart valves.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: March 30, 2021
    Assignee: LEONHARDT VENTURES LLC
    Inventors: Howard J. Leonhardt, Jorge Genovese
  • Patent number: 10953225
    Abstract: A topical nerve activation patch includes a flexible substrate, a dermis conforming bottom surface of the substrate comprising adhesive and adapted to contact a dermis of a user, a flexible top outer surface of the substrate approximately parallel to the bottom surface, a plurality of electrodes positioned on the patch proximal to the bottom surface and located beneath the top outer surface and coupled to the flexible substrate, a power source, and electronic circuitry that generates an output voltage applied to the electrodes. The electronic circuitry includes a controller, a voltage monitoring circuit coupled to the controller, a current monitoring circuit coupled to the controller, a switch coupled to the controller and a boosted voltage circuit coupled to the switch and the power source.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: March 23, 2021
    Assignee: Neurostim OAB, Inc.
    Inventors: Michael B. Druke, Alan E. Loh, Robert W. Scott, Anthony Wei, Graham Harold Creasey, Hoo-Min D. Toong
  • Patent number: 10926086
    Abstract: Methods are disclosed for preventing systemic infection or controlling metastases or providing a vaccine adjuvant in a subject, the methods comprising stimulating one or more peripheral nerves innervating one or more lymph nodes of the subject.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: February 23, 2021
    Assignee: The Feinstein Institutes for Medical Research
    Inventors: Sangeeta S. Chavan, William M. Hanes, Kevin J. Tracey
  • Patent number: 10874846
    Abstract: The present disclosure provides a TENS electrode needle and a TENS device. The TENS electrode needle includes: a needle handle having a first electrode and a second electrode for providing pulse current signals with different polarities are arranged; and at least one first needle body and at least one second needle body. Each of the first needle body and the second needle body includes a first end and a second end. The first end of the first needle body is electrically connected to the first electrode, and the first end of the second needle body is electrically connected to the second electrode, so as to form an electrical field between the second end of the first needle body and the second end of the second needle body.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: December 29, 2020
    Assignees: BOE TECHNOLOGY GROUP CO., LTD., HEFEI BOE OPTOELECTRONICS TECHNOLOGY CO., LTD.
    Inventor: Yangkun Jing
  • Patent number: 10849822
    Abstract: The disclosure discloses an antiemetic control device and a control method thereof, comprising a housing, a MCU single-chip microcontroller provided in the housing, a charging circuit, a discharging circuit and a rechargeable battery for supplying power, a button, a display screen, an alarm device and a plurality of mode indicator lights disposed on the housing, two electrodes and an optical pulse detecting unit disposed on the lower surface of the housing, and two wrist straps disposed on the housing. The disclosure has the characteristics of stable therapeutic effects.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: December 1, 2020
    Inventors: Jun Zhang, Yun Xiang, Lijuan Wang, Yurong Xu, Mingshan Sun
  • Patent number: 10842559
    Abstract: System and method for locating and identifying nerves innervating the wall of arteries such as the renal artery are disclosed. The present invention identifies areas on vessel walls that are innervated with nerves; provides indication on whether energy is delivered accurately to a targeted nerve; and provides immediate post-procedural assessment of the effect of energy delivered to the nerve. The method includes at least the steps to evaluate a change in physiological parameters after energy is delivered to an arterial wall; and to determine the type of nerve that the energy was directed to (none, sympathetic or parasympathetic) based on the evaluated results. The system includes at least a device for delivering energy to the wall of blood vessel; sensors for detecting physiological signals from a subject; and indicators to display results obtained using this method. Also provided are catheters for performing the mapping and ablating functions.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: November 24, 2020
    Assignee: SYMAP MEDICAL (SUZHOU), LIMITED
    Inventor: Jie Wang
  • Patent number: 10842560
    Abstract: An ablation catheter configured to ablate tissue in a lung of a patient including: a flexible shaft that advances endobronchially into an airway of the lung and has an outer diameter of 2.0 mm or less; an ablation electrode attached to a distal portion of the flexible shaft and to deliver radiofrequency (RF) electrical current to the tissue and conductively connectable to an RF electrical energy source external to the patient; wherein an outer diameter of an assembly of the flexible shaft and the ablation electrode is no greater than 2.0 mm; a liquid outlet on the distal portion and configured to be in fluid communication with a source of hypertonic saline solution; and a first occluder attached to the flexible shaft proximal to the ablation electrode and proximal to the liquid outlet, wherein the first occluder is configured to expand to occlude the airway.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: November 24, 2020
    Assignee: Zidan Medical Inc.
    Inventors: Dorin Panescu, Shashank Raina, Mark Gelfand, Mark Leung, Simplicio Velilla
  • Patent number: 10799221
    Abstract: A device for providing a magnetic force to a sampling needle. The device may include with a sheath having a proximal end and a distal end, a needle slidably received within the distal end of the sheath and an actuator component located at least partially within the distal end of the sheath, the actuator component configured to apply a magnetic force to the needle. The actuator component may include a coil located within the distal end of the sheath and a current source in electrical communication with the coil. The current source may include one or more capacitors, a DC power source, a first switch configured to cause the DC power source to charge the capacitors upon activation and a second switch configured to cause the capacitors to discharge to the coil upon activation.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: October 13, 2020
    Assignee: Gyrus ACMI, Inc.
    Inventor: Brandon J. Shuman
  • Patent number: 10780285
    Abstract: An implantable pulse generator (IPG) is disclosed having an improved ability to steer anodic and cathodic currents between the IPG's electrodes. Each electrode node has at least one PDAC/NDAC pair to source/sink or sink/source a stimulation current to an associated electrode node. Each PDAC and NDAC receives a current with a magnitude indicative of a total anodic and cathodic current, and data indicative of a percentage of that total that each PDAC and NDAC will produce in the patient's tissue at any given time, which activates a number of branches in each PDAC or NDAC. Each PDAC and NDAC may also receive one or more resolution control signals specifying an increment by which the stimulation current may be adjusted at each electrode. The current received by each PDAC and NDAC is generated by a master DAC, and is preferably distributed to the PDACs and NDACs by distribution circuitry.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: September 22, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Pujitha Weerakoon, David M. Wagenbach, Philip L. Weiss, Goran N. Marnfeldt, Kiran K. Gururaj
  • Patent number: 10741446
    Abstract: A method of wafer dicing includes singulating dies from a semiconductor wafer. The method further includes depositing a metal layer on back sides of the singulated dies, wherein a portion of the metal layer continues beyond the backs sides of the singulated dies to deposit at least partially on lateral sides of the singulated dies. A packaged die includes a semiconductor die and a metal outer layer deposited on the back side of the semiconductor die and on a portion of the lateral side of the semiconductor die nearest the back side. The packaged die further includes a substrate mounted to the back side of the semiconductor die a die attach material that bonds the substrate to the metal outer layer deposited on the semiconductor die, wherein the metal outer layer and the die attach material surround the back edge of the semiconductor die.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: August 11, 2020
    Assignee: NXP USA, Inc.
    Inventors: Jaynal A Molla, Lakshminarayan Viswanathan, David Abdo, Colby Greg Rampley, Fernando A. Santos
  • Patent number: 10682509
    Abstract: The present invention relates to a device for providing neuromuscular stimulation. The device comprises a positive electrode, a plurality of negative electrodes, a non-conductive substrate and a control unit for activating the electrodes. The control unit of the device activates the negative electrodes in a predetermined sequence, so as to deliver electrical stimulus to a user, wherein the predetermined sequence is repeated with an increasing level of stimulus until a predetermined outcome is achieved. Additionally each negative electrode of the devices comprises at least one conductive track mounted on the non-conductive substrate wherein at least one pair of negative electrodes overlap such that the conductive track or tracks of a first negative electrode of the pair overlap with the electrode footprint, but not the conductive tracks, of a second negative electrode of the pair.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: June 16, 2020
    Assignee: Sky Medical Technology Ltd
    Inventors: Jonathan Fenton, Duncan Bain, Martin Gordon, Benjamin Gordon
  • Patent number: 10646164
    Abstract: A wirelessly powered implantable stimulator device includes one or more antenna configured to receive an input signal non-inductively from an external antenna, the input signal containing (i) electrical energy to operate the implantable stimulator device and (ii) configuration data according to which a pulse-density modulation (PDM) encoded stimulus waveform signal is retrieved to synthesize a desired stimulation waveform; a circuit coupled to the one or more antenna; and one or more electrodes coupled to the circuit and configured to apply the desired stimulation waveform to neural tissue, wherein the circuit is configured to: rectify the input signal received at the one or more antennas non-inductively; extract the electrical energy and the configuration data from the input signal; and in accordance with the extracted configuration data, retrieve the pulse-density modulation (PDM) signal to synthesize the desired stimulation waveform therefrom.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: May 12, 2020
    Assignee: Stimwave Technologies Incorporated
    Inventors: Laura Tyler Perryman, Bertan Bakkaloglu, Chad David Andresen
  • Patent number: 10617880
    Abstract: A system and method for powering a medical device that includes a fixture configured for periodic patient proximity; external electrical coupling device integrated into the fixture wherein the external electrical coupling device comprises at least one external energy coupler and is configured to detect presence of an electrical medical device implant in a transmission zone of the external electrical coupling device; an electrical medical device implant, wherein the electrical medical device implant comprises at least one implant energy coupler; and wherein the external electrical coupling device is configured to couple to the implantable medical device through a wireless energy transmission between the external energy coupler and the implant energy coupler when presence of the implantable medical device is within a transmission zone.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: April 14, 2020
    Assignee: Intelligent Implants Limited
    Inventors: Erik Zellmer, John Zellmer, Rory Murphy
  • Patent number: 10593231
    Abstract: A system for monitoring stomach fullness includes an ultrasound transponder configured to transmit ultrasound signals and receive reflected ultrasound signals. A processor is configured to process the received reflected ultrasound signals to determine level of stomach fullness and output fullness data indicative of the determined level of stomach fullness. A memory stores calibration data representative of calibrated levels of stomach fullness including empty and full. A stored program has executable codes to, upon execution, control the ultrasound transponder, compare the fullness data against the calibration data, and output alert data upon a match of a preset fullness level.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: March 17, 2020
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Amos Cahan, Theodore Gerard Van Kessel
  • Patent number: 10518088
    Abstract: The invention comprises SCENAR-therapy or other methods of electric stimulation, where an inductive energy storage unit is used to generate stimuli, and can be applied for therapeutic, rehabilitation, research, and preventive purposes. The invention includes applying electrodes on tissues and transmitting through them bursts of electrical stimuli. The stimuli are controlled based on processes occurring in these tissues as a result of their interaction with the electrical stimuli. The exposure duration and/or stimuli parameters are controlled according to the free oscillation parameters. The invention includes three types of parameter measurements: measuring parameters while the current stimulus burst is acting; measuring parameters of the last stimulus of each burst; and generating a probing sole stimulus before the main burst and measuring parameters of this stimulus.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: December 31, 2019
    Assignee: RITM OKB ZAO
    Inventors: Yakov Zalmanovich Grinberg, Yury Yurievich Starovoytov, Mikhail Anatolievich Unakafov
  • Patent number: 10485971
    Abstract: A system and method for the transcutaneous stimulation of various nerves such as the phrenic, hypoglossal, and vagal nerves is provided. The stimulation elicits a corresponding muscle response without reported pain.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: November 26, 2019
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, Carolyn Y. Sargent
  • Patent number: 10485605
    Abstract: An apparatus and method stimulate or sense neurons or groups of neurons in a subject, e.g., a human or animal brain, with positional dependence. This utility is provided in part by utilizing individually-addressable Radio-Frequency IDentification (RFID) coils so that locations of those coils in the brain would be monitored and known.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: November 26, 2019
    Assignee: Weinberg Medical Physics, Inc.
    Inventor: Irving N. Weinberg
  • Patent number: 10449355
    Abstract: A system for restoring muscle function to the lumbar spine to treat low back pain is provided. The system may include one or more electrode leads coupled to an implantable pulse generator (IPG) and a tunneler system for subcutaneously implanting a proximal portion of the lead(s). The system may also include a handheld activator configured to transfer a stimulation command to the IPG, and an external programmer configured to transfer programming data to the IPG. The stimulation command directs the programmable controller to stimulate the tissue in accordance with the programming data. The system may include a software-based programming system run on a computer such that the treating physician may program and adjust stimulation parameters.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: October 22, 2019
    Assignee: Mainstay Medical Limited
    Inventors: John Beck, Jason Skubitz, Peter Crosby, Henry DeMorett, Jason Alan Shiroff
  • Patent number: 10426945
    Abstract: Transdermal electrical stimulation (TES) applicators that are wearable and configured to attached to a subject's pinna (ear) and adapted to apply TES to modulate the subject's cognitive and/or physiological state. These apparatuses may be configured so that they can be worn against the ear (e.g., the cymba of the ear) to deliver TES. Also described herein are methods of using them to modulate a subject's cognitive state. These TES applicators may also be adapted to function as audio headphones for concurrent delivery of TES and audible signals (e.g., music).
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: October 1, 2019
    Assignee: Thync Global, Inc.
    Inventors: William J. Tyler, Wing Law, Douglas Jeffery, Rafal Piersiak